As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Read here for more on the potential of RCUS's combination therapies for various cancers, with promising Phase 3 trials and ...

The liver cirrhosis treatment market is poised for significant growth, driven by the rising global prevalence of liver diseases, particularly NAFLD, fueled by lifestyle factors like obesity, alcohol ...

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ahead.